You may read previous posting (Part 1):
- Could Available Drugs Regenerate beta Cells? – Part 1 - Diabetes 28
In addition to treat diabetes, GLP-1 receptor agonists (GLP-1 Ras) have other several advantages:
- heart health
- and kidney function
Researchers from Icahn medical school, Mount Sinai, New York combined both DYRK1A inhibitors and GLP-1 receptor agonists to see their effect on beta cell replication on human with diabetes.
The result is quite surprising!
Finding of research may be summarized as following:
1) It is possible to replicate beta cells in diabetes patients
- previous research was fail.
2) Combine drugs able to produce beta cells in quite numbers
- about 5% to 6% after four days treatment.
- while using GLP-1 receptor agonist alone produce 2% beta cells only
3) Further developments
- Scientists believe that combines with other inhibitor drugs could increase cells replications significantly.
# Previous postings:
- What Effect of Diversity Patrons on the Arts in the 15th-18th centuries? - part 1
- Is it Norm to Hire Underage Workers in Developing Countries? - part 1
- Is Aarhus, Denmark the Happiest City in the World?